About Ingeneron
Ingeneron is a company based in Houston (United States) founded in 2005.. Ingeneron has raised $51.4 million across 5 funding rounds from investors including Sanford Health. Ingeneron operates in a competitive market with competitors including Horizon Therapeutics, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.4 M (USD)
in 5 rounds
-
Latest Funding Round
$1.75 M (USD), Series D
Feb 16, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Software Development Team
2 people
Finance and Accounting
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Ingeneron
Ingeneron has successfully raised a total of $51.4M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $1.75 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $1.7M
-
First Round
First Round
(07 Jul 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series D - Ingeneron | Valuation |
investors |
|
| Apr, 2019 | Amount | Series D - Ingeneron | Valuation | Sanford Health |
|
| Mar, 2017 | Amount | Series D - Ingeneron | Valuation | Sanford Health |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ingeneron
Ingeneron has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sanford Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Operator of integrated healthcare system providing medical services and health plans
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ingeneron
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ingeneron
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ingeneron Comparisons
Competitors of Ingeneron
Ingeneron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ingeneron
Frequently Asked Questions about Ingeneron
When was Ingeneron founded?
Ingeneron was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Where is Ingeneron located?
Ingeneron is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is Ingeneron a funded company?
Ingeneron is a funded company, having raised a total of $51.4M across 5 funding rounds to date. The company's 1st funding round was a Series D of $20M, raised on Jul 07, 2016.
What does Ingeneron do?
Ingeneron was founded in 2005 and is based in Houston, United States. Cell-based technologies are provided for healthcare, veterinary medicine, and life science research. Adipose-derived regenerative cells, including stem cells, are isolated through proprietary separation methods. These cells are utilized in treatments for diseases, orthopedic injuries, and cosmetic procedures by medical professionals.
Who are the top competitors of Ingeneron?
Ingeneron's top competitors include Sutro Biopharma, Horizon Therapeutics and Avidity Biosciences.
Who are Ingeneron's investors?
Ingeneron has 1 investor. Key investors include Sanford Health.